Signaling defects in T lymphocytes of patients with malignancy

Cancer Immunology Immunotherapy

Volumn 48, Issue 7, 1999, Pages 346-352

  Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

chain expression; Lymphocyte apoptosis; Malignancy; Tumor infiltrating lymphocytes

Indexed keywords

APOPTOSIS; CANCER; CONFERENCE PAPER; FLOW CYTOMETRY; HELPER CELL; HUMAN; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; APOPTOSIS; DNA FRAGMENTATION; DOWN-REGULATION; HUMANS; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MEMBRANE PROTEINS; MICE; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0032824973     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050585     Document Type: Conference Paper

References (47)

1. Whiteside TL (1993) Tumor-infiltrating lymphocytes in human solid tumors. R.G. Landes, Austin
2. Whiteside TL, Parmiani G (1994) Tumor-infiltrating lymphocytes: their phenotype function and clinical use. Cancer Immunol Immunother 39:15-21
3. Underwood JCE (1974) Lymphoreticular infiltration in human tumors: prognostic and biologic implications. A review. Br J Cancer 30:538-548
4. Ioachim HL (1979) The stroma reaction of tumors: an expression of immune surveillance. J Natl Cancer Inst 57:465-475
5. Stewart THM, Tsai S-CJ (1993) The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer. Clin Exp Metastasis 11:295-305
6. Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB, Whiteside TL (1991) Characterization of human autotumor-reactive T cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res 51:6153-6162
7. Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB, Whiteside TL (1993) Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res 53:1461-1468
8. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Rosenberg SA (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A 91:6458-6462
9. Kawakami Y, Rosenberg SA (1997) Human tumor antigens recognized by T cells. Immunol Res 16:313-339
10. Miescher S, Whiteside TL, Moretta L, VonFliedner V (1987) Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. J Immunol 138:4004-4011
11. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, von Fliedner V (1998) Proliferative and cytolytic potentials of purified human tumor infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T cell receptor expression. Int J Cancer 42:659-666
12. Whiteside TL, Jost LM, Herberman RB (1992) Tumor-infiltrating lymphocytes: potential and limitations to their use for cancer therapy. Crit Rev Oncol Hematol 12:25-47
13. Whiteside TL (1992) Tumor-infiltrating lymphocytes as antitumor effector cells. Biotherapy 5:47-61
14. Rabinowich H, Suminami Y, Reichert TE, Crowley-Nowick P, Bell M, Edwards R, Whiteside TL (1996) Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. Int J Cancer 68:276-284
15. Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, Finke J, Bukowski RM (1995) Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 61:780-785
16. Miescher S, Whiteside TL, Carrell S, Von Fliedner V (1986) Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899-1907
17. Reichert TE, Rabinowich H, Johnson JT, Whiteside TL (1998) Immune cells in the tumor microenvironment: mechanisms responsible for signaling and functional defects. J Immunother 21:295-306
18. Weiss A, Littman DR (1994) Signal transduction by lymphocyte antigen receptors. Cell 76:263-274
19. Kono K, Ressing ME, Brandt RMP, Melief CJM, Potkul RK, Andersson B, Petersson M, Kast WM, Kiessling R (1996) Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 2:1825-1828
20. Matsuda M, Petersson M, Lenke R, Taupin J-L, Magnusson I, Mellstedt H, Anderson P, Kiessling R (1995) Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer 61:765-772
21. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin J-L, Vivier E, Anderson P, Kiessling R (1993) Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610-5612
22. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53:5613-5616
23. Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL (1996) Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 2:161-173
24. Loeffler CM, Smyth MJ, Longo DL, Kopp WC, Harvery LK, Tribble HR, Tase JE, Urba WJ, Leonard AS, Young HA, Ochoa AC (1992) Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells. J Immunol 149:949-956
25. Mizogushi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alteration in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1975-1978
26. Healy CG, Simons JW, Carducci MA, DeWeese TL, Bartkowski M, Tong KP, Bolton WE (1998) Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry 32:109-119
27. Zea AH, Brendan CD, Longo DL, Alvord WG, Strobl SL, Mizoguchi H, Creekmore SP, O'Shea JJ, Powers GC, Urba WJ, Ochoa AC (1995) Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1:1327-1335
28. Rabinowich H, Banks M, Reichert TE, Logan TF, Kirkwood JM, Whiteside TL (1996) Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin Cancer Res 2:1263-1272
29. fγn, ZAP-70, and CD3ζ despite suppressed cytolytic activity. J Exp Med 182:1029-1036
30. Aoe T, Okamoto Y, Saito T (1995) Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 181:1881-1886
31. Kuss I, Saito T, Johnson JT, Whiteside TL (1999) Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 5:329-334
32. Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C, Kiessling R (1995) Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 63:366-372
33. Luscher U, Filgueira L, Juretic A, Zuber M, Luscher NJ, Heberer M, Spagnoli GC (1994) The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int J Cancer 57:612-619
34. Rabinowich H, Reichert TE, Kashii Y, Bell MC, Whiteside TL (1998) Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells: implications for altered expression of TcR in tumor-associated lymphocytes. J Clin Invest 101:2579-2588
35. Gastman BR, Whiteside TL, Rabinowich H (1998) Mechanisms of cytokine-mediated protection of lymphocytes from tumor-induced apoptosis (abstract 993). Proc Am Assoc Cancer Res 39:145
36. Gastman BR, Johnson DE, Whiteside TL, Rabinowich J (1999) Caspase-mediated degradation of TcR-ζ chain. Cancer Res 59:1422-1427
37. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, Nakazawa T, Anderson P, Kiessling R (1996) Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ζ molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytoxicity. Eur J Immunol 26:1308
38. Zea AH, Ochoa MT, Ghosh P, Longo DL, Alvord WG, Valderrama L, Falabella R, Harvey LK, Saravia N, Moreno LH, Ochoa AC (1998) Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun 66:499
39. Stefanova I, Saville MW, Peters C, Cleghorn FR, Schwartz D, Venzon DJ, Weinhold KJ, Jack N, Bartholomew C, Blattner WA, Yarchoan R, Bolen JB, Horak ID (1996) HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest 98:1290-1297
40. Reichert TE, Day R, Wagner E, Whiteside TL (1998) Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res 58:5344-5347
41. Cardi G, Heaney JA, Schned AR, Phillips DM, Branda MT, Ernstoff MS (1997) T-cell receptor ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma. Cancer Res 57:3517-3519
42. Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL (1999) Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 5:1263-1273
43. Tartour E, Latour S, Mathiot C, Thiounn N, Mosser V, Joyeux I, D'Enghien CD, Lee R, Debre B, Fridman WH (1995) Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 63:205-212
44. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM, Finke J (1993) T cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin-2 and express interleukin-2 receptors. Cancer Res 53:1380-1387
45. Tschopp J, Irmler M, Thome M (1998) Inhibition of Fas death signals by FLIPS. Curr Opin Immunol 10:552-558
46. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16:6914-6925
47. Farace F, Angevin E, Vanderplancke J, Escudier B, Triebel F (1994) The decreased expression of CD3 ζ chains in cancer patients is not reversed by IL-2 administration. Int J Cancer 59:752-755